Cardiovascular System to merge with Replidyne

Cardiovascular Systems Inc. (CSI) has entered into a definitive merger agreement under which CSI will merge with Struggling biotech company Replidyne Inc in an all-stock merger valued at up to $40 million.

CSI is a medical device company focused on developing and commercializing interventional treatment systems for vascular disease.

Genzye Corp inks alliance with Orisis Therapeutics

Genzye Corp. has signed a stem cell treatment development and sales deal with stem cell company Orisis Therapeutics to develop two new treatments.

Under the deal, Genzyme will make an upfront $130 million payment to Osiris for rights to the company's developing Prochymal and Chondrogen treatments.

An official release stated that Osiris would commercialize both drugs in the U.S. and Canada, while Genzyme would have sales rights in all other countries.

Apart from this, Osiris could receive up to $1.25 billion in milestone payments, based on the drugs' development and eventual sales.

Bayside Capital acquires Flight Express

Bayside Capital, Inc. has notified that its affiliate has acquired Flight Express, Inc.

Florida-based Flight Express is a premier provider of high-security, same-day air courier services to banking and life sciences customers in the South and Midwest region.

The company is the world's largest operator of Cessna 210 aircraft and operates 84 aircraft from facilities in eight states. The firm provides value-added, time-critical aviation services to a diverse set of customers in the most service-intensive, cost-effective manner possible.

Juhl Wind completes acquisition of Next Generation Power System

Juhl Wind Inc., an established leader in Community Based Wind Power development and management,, has informed that it has completed its acquisition of Next Generation Power Systems - a company that specializes in community scale wind turbine and solar systems.

Woodstock-based Juhl Wind is an established leader in Community Based Wind Power development and management, focused on wind farm projects throughout the United States and Canada.

Artificial pancreas for diabetics

Researchers at Boston University are developing artificial pancreas for diabetic patients. The gland would be worn externally. It would improve blood sugar level monitoring and would be helpful for patients with type I diabetes.

Pages

News in Focus

CATL and its Brunp Recycling subsidiary are setting up JV for cathode materials

In a move which will enable Chinese battery manufacturer CATL to expand its raw material supply, a joint venture for cathode materials is being set up by the company with its subsidiary Brunp Recyc

Chinese government aiming at 1 million FCEV registrations by 2030

According to a report by the South China Morning Post, the Chinese government is aiming for an ambitious target of getting 1 million fuel cell vehicles (FCEVs) on the roads by the year 2030.

VW ID.3 special edition, limited to 30,000 units, is out of stock

In a recent statement released shortly ahead of the upcoming IAA event this week, German automaker Volkswagen (VW) has revealed that its limited special edition of the ID.3 is now out of stock.

Porsche unveils final production version of ‘Taycan’ all-electric car

German automaker Porsche officially unveiled the final production version its first all-electric car -- the ‘Taycan’ -- on Wednesday, September 4, 2019.

BMW to discontinue hybrid i8 production by April 2020

In a recent press release, German automaker BMW has indicated that it will stop producing its i8 plug-in hybrid sports car from April 2020.

Fraunhofer ISE develops EV solar roof with highly efficient solar cells

Germany-based Fraunhofer Institute for Solar Energy Systems (Fraunhofer ISE) has developed solar roofing for electric vehicles (EVs), in an apparent effort to increase their driving range.

CNH Industrial invests $250M in e-truck start-up Nikola

In a recent statement, UK-headquartered capital goods company CNH Industrial has revealed that it is making a $250-million investment in US startup Nikola, which specializes in the production of el